Funding Tracker/Evvy
Series B · Women's Health / Diagnostics · United States
Evvy raises $40M
Announced September 15, 2026
The round
Evvy announced a Series B round of $40M on September 15, 2026, led by Catalio Capital Management.
The SignalOversubscribed Series B to clinically validate AI diagnostic and care models starting with fertility.
What Evvy does
Develops at-home vaginal microbiome testing kits and personalized care plans.
Evvy provides an at-home vaginal microbiome test using metagenomic next-generation sequencing. The company offers individuals detailed breakdowns of their vaginal bacteria and yeast, alongside access to clinical coaching, customized treatment recommendations, and educational resources to address chronic vaginal infections.
Full Evvy profile- Company
- Evvy
- Amount
- $40M
- Stage
- Series B
- Announced
- September 15, 2026
- Led by
- Catalio Capital Management
- Vertical
- Women's Health / Diagnostics
- Country
- United States
- Headquarters
- New York, USA
- Founded
- 2021